sales@theinsightpartners.com
+1-646-491-9876 +44-20-8125-4005

Asia Pacific Gastrointestinal Drugs Market Scope And Analysis

  • Report Code : TIPRE00016279
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 147
Buy Now

Asia Pacific Gastrointestinal Drugs Market Analysis, Trends, and Scope 2020 to 2027

Buy Now

Asia Pacific Gastrointestinal Drugs Market Report Asia Pacific Gastrointestinal Drugs Market Size and Share Asia Pacific Gastrointestinal Drugs Market Scope and Analysis

Asia Pacific Gastrointestinal Drugs Market Report Scope

Report Attribute Details
Market size in 2019 US$ 8,868.44 Million
Market Size by 2027 US$ 13,618.35 Million
Global CAGR (2020 - 2027) 5.6%
Historical Data 2017-2018
Forecast period 2020-2027
Segments Covered By Drug Class
  • Acid Neutralizers
  • Antidiarrheal and Laxatives
  • Anti-Inflammatory Drugs
  • Antiemetic and Antinauseants
  • Biologics
By Route of Administration
  • Oral
  • Parenteral
By Application
  • Inflammatory Ulcerative Colitis
  • Crohn's Disease
  • Irritable Bowel Syndrome
  • Gastroenteritis
  • Celiac Disease
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Regions and Countries Covered Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
Market leaders and key company profiles
  • Johnson and Johnson Services Inc
  • GlaxoSmithKline plc
  • Celltrion Healthcare Co Ltd
  • AstraZeneca
  • Takeda Pharmaceutical Company Limited
    		•